Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Alphatec sells $2.37M in common stock » 18:53
01/24/23
01/24
18:53
01/24/23
18:53
ATEC

Alphatec

$12.98 /

-0.18 (-1.37%)

In a regulatory filing,…

In a regulatory filing, Alphatec disclosed that its CEO Patrick Miles sold 180K shares of common stock on January 20th in a total transaction size of $2.37M.

ShowHide Related Items >><<
ATEC Alphatec
$12.98 /

-0.18 (-1.37%)

ATEC Alphatec
$12.98 /

-0.18 (-1.37%)

01/12/23 Lake Street
Alphatec price target raised to $20 from $16.50 at Lake Street
01/09/23 Piper Sandler
Piper Sandler reiterates Overweight on Alphatec after solid Q4 beat, 2023 guide
10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
ATEC Alphatec
$12.98 /

-0.18 (-1.37%)

ATEC Alphatec
$12.98 /

-0.18 (-1.37%)

Hot Stocks
Alphatec CEO sells $2.38M in common stock » 20:45
01/19/23
01/19
20:45
01/19/23
20:45
ATEC

Alphatec

$13.45 /

-0.04 (-0.30%)

In a regulatory filing,…

In a regulatory filing, Alphatec disclosed that its CEO Patrick Miles sold 180K shares of common stock on January 17th in a total transaction size of $2.38M.

ShowHide Related Items >><<
ATEC Alphatec
$13.45 /

-0.04 (-0.30%)

ATEC Alphatec
$13.45 /

-0.04 (-0.30%)

01/12/23 Lake Street
Alphatec price target raised to $20 from $16.50 at Lake Street
01/09/23 Piper Sandler
Piper Sandler reiterates Overweight on Alphatec after solid Q4 beat, 2023 guide
10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
ATEC Alphatec
$13.45 /

-0.04 (-0.30%)

ATEC Alphatec
$13.45 /

-0.04 (-0.30%)

Recommendations
Alphatec price target raised to $20 from $16.50 at Lake Street » 08:49
01/12/23
01/12
08:49
01/12/23
08:49
ATEC

Alphatec

$12.04 /

+0.1 (+0.84%)

Lake Street analyst…

Lake Street analyst Brooks O'Neil raised the firm's price target on Alphatec to $20 from $16.50 and keeps a Buy rating on the shares after the company released preliminary Q4 results and initial FY23 guidance that were both above his forecast and consensus. The results, and the company's announcement of a new $150M term loan from current investor Braidwell, "suggest the journey for ATEC and investors is just beginning," O'Neil said.

ShowHide Related Items >><<
ATEC Alphatec
$12.04 /

+0.1 (+0.84%)

ATEC Alphatec
$12.04 /

+0.1 (+0.84%)

01/09/23 Piper Sandler
Piper Sandler reiterates Overweight on Alphatec after solid Q4 beat, 2023 guide
10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
ATEC Alphatec
$12.04 /

+0.1 (+0.84%)

ATEC Alphatec
$12.04 /

+0.1 (+0.84%)

ATEC Alphatec
$12.04 /

+0.1 (+0.84%)

Conference/Events
Alphatec management to meet with Piper Sandler » 04:55
01/10/23
01/10
04:55
01/10/23
04:55
ATEC

Alphatec

$11.95 /

-0.61 (-4.86%)

Piper Sandler holds a…

Piper Sandler holds a dinner meeting with management during the JPMorgan Healthcare Conference in San Francisco on January 10.

ShowHide Related Items >><<
ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

01/09/23 Piper Sandler
Piper Sandler reiterates Overweight on Alphatec after solid Q4 beat, 2023 guide
10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

On The Fly
What You Missed On Wall Street On Monday » 16:24
01/09/23
01/09
16:24
01/09/23
16:24
NVEI

Nuvei

$27.93 /

+0.93 (+3.44%)

, PAYA

Paya Holdings

$9.69 /

+1.895 (+24.33%)

, AZN

AstraZeneca

$70.89 /

+0.1 (+0.14%)

, CINC

CinCor Pharma

$28.70 /

+16.885 (+142.91%)

, IPSEY

Ipsen

$26.39 /

+ (+0.00%)

, ALBO

Albireo Pharma

$43.85 /

+21.05 (+92.32%)

, DCT

Duck Creek Technologies

$19.04 /

+6.045 (+46.52%)

, LULU

Lululemon

$298.59 /

-30.89 (-9.38%)

, Z

Zillow

$38.74 /

+2.87 (+8.00%)

, ZG

Zillow Group

$37.78 /

+2.81 (+8.04%)

, MA

MasterCard

$371.05 /

+3.15 (+0.86%)

, V

Visa

$218.59 /

+0.77 (+0.35%)

, UBER

Uber

$27.40 /

+1.015 (+3.85%)

, DASH

DoorDash

$48.06 /

+0.045 (+0.09%)

, GDDY

GoDaddy

$74.32 /

-0.2 (-0.27%)

, CMCSA

Comcast

$37.55 /

-0.31 (-0.82%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, CS

Credit Suisse

$3.35 /

+0.075 (+2.29%)

, MRNA

Moderna

$183.90 /

+3.51 (+1.95%)

, DIS

Disney

$94.78 /

+0.86 (+0.92%)

, AAPL

Apple

$130.16 /

+0.59 (+0.46%)

, AMYT

Amryt Pharma

$14.51 /

+7.425 (+104.80%)

, RVNC

Revance

$30.41 /

+10.69 (+54.21%)

, CVAC

CureVac

$10.34 /

+2.09 (+25.33%)

, CUTR

Cutera

$30.99 /

-9.32 (-23.12%)

, CERS

Cerus

$2.72 /

-1.07 (-28.27%)

, M

Macy's

$20.44 /

-1.69 (-7.64%)

, DXCM

DexCom

$110.07 /

-5.77 (-4.98%)

, ATEC

Alphatec

$11.95 /

-0.61 (-4.86%)

, PFE

Pfizer

$48.38 /

-2.525 (-4.96%)

, SRPT

Sarepta

$117.73 /

-4.36 (-3.57%)

Get caught up quickly on…

ShowHide Related Items >><<
ZG Zillow Group
$37.78 /

+2.81 (+8.04%)

Z Zillow
$38.74 /

+2.87 (+8.00%)

V Visa
$218.59 /

+0.77 (+0.35%)

UBER Uber
$27.40 /

+1.015 (+3.85%)

SRPT Sarepta
$117.73 /

-4.36 (-3.57%)

RVNC Revance
$30.41 /

+10.69 (+54.21%)

PFE Pfizer
$48.38 /

-2.525 (-4.96%)

NVEI Nuvei
$27.93 /

+0.93 (+3.44%)

MRNA Moderna
$183.90 /

+3.51 (+1.95%)

MA MasterCard
$371.05 /

+3.15 (+0.86%)

M Macy's
$20.44 /

-1.69 (-7.64%)

LULU Lululemon
$298.59 /

-30.89 (-9.38%)

IPSEY Ipsen
$26.39 /

+ (+0.00%)

GDDY GoDaddy
$74.32 /

-0.2 (-0.27%)

DXCM DexCom
$110.07 /

-5.77 (-4.98%)

DIS Disney
$94.78 /

+0.86 (+0.92%)

DCT Duck Creek Technologies
$19.04 /

+6.045 (+46.52%)

DASH DoorDash
$48.06 /

+0.045 (+0.09%)

CVAC CureVac
$10.34 /

+2.09 (+25.33%)

CUTR Cutera
$30.99 /

-9.32 (-23.12%)

CS Credit Suisse
$3.35 /

+0.075 (+2.29%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$37.55 /

-0.31 (-0.82%)

CINC CinCor Pharma
$28.70 /

+16.885 (+142.91%)

CERS Cerus
$2.72 /

-1.07 (-28.27%)

AZN AstraZeneca
$70.89 /

+0.1 (+0.14%)

ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

AMYT Amryt Pharma
$14.51 /

+7.425 (+104.80%)

ALBO Albireo Pharma
$43.85 /

+21.05 (+92.32%)

AAPL Apple
$130.16 /

+0.59 (+0.46%)

NVEI Nuvei
$27.93 /

+0.93 (+3.44%)

01/10/23 Credit Suisse
Paya Holdings downgraded to Neutral from Outperform at Credit Suisse
01/09/23 BTIG
Paya Holdings downgraded to Neutral from Buy at BTIG
01/09/23 Goldman Sachs
Nuvei upgraded to Buy from Neutral at Goldman Sachs
01/05/23 Wolfe Research
Nuvei price target lowered to $35 from $42 at Wolfe Research
PAYA Paya Holdings
$9.69 /

+1.895 (+24.33%)

01/10/23 Canaccord
Paya Holdings downgraded to Hold from Buy at Canaccord
01/09/23 Raymond James
Paya Holdings downgraded to Market Perform from Outperform at Raymond James
AZN AstraZeneca
$70.89 /

+0.1 (+0.14%)

01/05/23 BMO Capital
AstraZeneca initiated with an Outperform at BMO Capital
01/03/23 JPMorgan
AstraZeneca price target raised to 13,500 GBp from 12,500 GBp at JPMorgan
12/15/22 Deutsche Bank
AstraZeneca price target raised to 13,000 GBp from 12,000 GBp at Deutsche Bank
11/04/22 Citi
Citi opens 'positive catalyst watch' AstraZeneca on NJ litigation outcomes
CINC CinCor Pharma
$28.70 /

+16.885 (+142.91%)

12/07/22 Barclays
CinCor Pharma initiated with an Overweight at Barclays
11/30/22 Jefferies
Jefferies defending CinCor Pharma 'at zero EV'
11/29/22 Morgan Stanley
CinCor Pharma downgraded on limited catalysts at Morgan Stanley
11/29/22 Morgan Stanley
CinCor Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
IPSEY Ipsen
$26.39 /

+ (+0.00%)

01/09/23 Piper Sandler
Albireo acquisition 'good news' for Mirum Pharmaceuticals, says Piper Sandler
01/09/23 Wedbush
Albireo Pharma downgraded to Neutral from Outperform at Wedbush
12/09/22 Oddo BHF
Ipsen downgraded to Neutral from Outperform at Oddo BHF
12/06/22 Barclays
Ipsen reinstated with an Equal Weight at Barclays
ALBO Albireo Pharma
$43.85 /

+21.05 (+92.32%)

10/24/22 Piper Sandler
Mirum's LIVMARLI PFIC data shows superiority to Albireo's Bylvay, says Piper
10/12/22 H.C. Wainwright
Albireo Pharma price target raised to $68 from $54 at H.C. Wainwright
DCT Duck Creek Technologies
$19.04 /

+6.045 (+46.52%)

01/10/23 William Blair
Duck Creek downgraded to Market Perform from Outperform at William Blair
01/09/23 Needham
Duck Creek Technologies downgraded to Hold from Buy at Needham
01/04/23 BofA
Duck Creek Technologies downgraded to Underperform from Neutral at BofA
12/29/22 Raymond James
Duck Creek 2023 outlook 'much improved' on relative basis, says Raymond James
LULU Lululemon
$298.59 /

-30.89 (-9.38%)

01/10/23 Raymond James
Lululemon added to 'Analyst Current Favorites' at Raymond James
01/10/23 Cowen
Lululemon price target lowered to $488 from $516 at Cowen
01/10/23 Deutsche Bank
Lululemon price target lowered to $422 from $447 at Deutsche Bank
01/10/23 Baird
Lululemon weakness a buying opportunity, says Baird
Z Zillow
$38.74 /

+2.87 (+8.00%)

01/09/23 BofA
Zillow Group upgraded to Buy from Underperform at BofA
12/21/22 Piper Sandler
Piper says slowing housing market still a 'headwind' for Redfin, Zillow
12/13/22 Citi
Zillow Group initiated with a Buy at Citi
11/04/22 Evercore ISI
Zillow Group removed from 'Tactical Underperform' list at Evercore ISI
ZG Zillow Group
$37.78 /

+2.81 (+8.04%)

12/02/22 UBS
Zillow Group initiated with a Buy at UBS
MA MasterCard
$371.05 /

+3.15 (+0.86%)

01/09/23 KeyBanc
MasterCard upgraded to Overweight from Sector Weight at KeyBanc
01/05/23 Wolfe Research
MasterCard price target raised to $415 from $395 at Wolfe Research
12/27/22 Wedbush
Wedbush says SpendingPulse data bodes well for Visa, MasterCard, and PayPal
12/27/22 Baird
Baird doubts FTC order will have 'material impact' on MasterCard
V Visa
$218.59 /

+0.77 (+0.35%)

01/09/23 KeyBanc
Visa upgraded to Overweight from Sector Weight at KeyBanc
01/05/23 Wolfe Research
Visa price target raised to $255 from $240 at Wolfe Research
12/02/22 Wells Fargo
Visa price target raised to $250 from $225 at Wells Fargo
UBER Uber
$27.40 /

+1.015 (+3.85%)

01/09/23 Jefferies
Uber assumed with a Buy at Jefferies
01/09/23 Piper Sandler
Uber upgraded to Overweight from Neutral at Piper Sandler
01/06/23 Needham
Genius Sports named 2023 Top Pick, added to Conviction List at Needham
01/03/23 BTIG
Expedia named Top Pick for first half of 2023 at BTIG
DASH DoorDash
$48.06 /

+0.045 (+0.09%)

01/09/23 Jefferies
DoorDash initiated with an Underperform at Jefferies
01/09/23 Piper Sandler
DoorDash downgraded to Underweight from Neutral at Piper Sandler
01/05/23 Mizuho
DoorDash price target lowered to $65 from $70 at Mizuho
GDDY GoDaddy
$74.32 /

-0.2 (-0.27%)

01/09/23 Jefferies
GoDaddy downgraded to Hold from Buy at Jefferies
12/13/22 Citi
GoDaddy initiated with a Buy at Citi
11/11/22 JPMorgan
GoDaddy initiated with an Overweight at JPMorgan
11/04/22 Raymond James
GoDaddy price target lowered to $88 from $100 at Raymond James
CMCSA Comcast
$37.55 /

-0.31 (-0.82%)

01/06/23 MKM Partners
MKM Partners sees WWE as 'very attractive asset' if it goes for sale
01/05/23 Truist
Truist upgrades Comcast, Charter to Buy with risks 'well understood'
01/05/23 Truist
Comcast upgraded to Buy from Hold at Truist
12/12/22 Morgan Stanley
Comcast has catalysts for re-rating, says Morgan Stanley
CMCSK Comcast
$58.00 /

+ (+0.00%)

09/27/22 Credit Suisse
Charter price target lowered to $551 from $676 at Credit Suisse
09/27/22 Credit Suisse
Comcast price target lowered to $51 from $57 at Credit Suisse
07/20/22 KeyBanc
Disney price target lowered to $131 from $151 at KeyBanc
05/23/22 Raymond James
Electronic Arts moves 'somewhat unexpected,' says Raymond James
CS Credit Suisse
$3.35 /

+0.075 (+2.29%)

12/20/22 Exane BNP Paribas
Credit Suisse resumed with an Underperform at Exane BNP Paribas
12/20/22 Citi
Credit Suisse resumed with a Buy at Citi
12/19/22 RBC Capital
Credit Suisse reinstated with a Sector Perform at RBC Capital
12/09/22 BofA
BofA upgrades Credit Suisse to Buy, sees more than 20% upside potential
MRNA Moderna
$183.90 /

+3.51 (+1.95%)

01/05/23 Morgan Stanley
Morgan Stanley sees Moderna's phase 3 RSV vaccine data as catalyst-driven idea
12/20/22 Piper Sandler
Moderna price target raised to $217 from $214 at Piper Sandler
12/19/22 Jefferies
Moderna upgraded to Buy from Hold at Jefferies
12/16/22 Morgan Stanley
Moderna price target raised to $209 from $170 at Morgan Stanley
DIS Disney
$94.78 /

+0.86 (+0.92%)

01/04/23 Macquarie
Disney price target lowered to $110 from $120 at Macquarie
12/20/22 Wells Fargo
Wells says Disney spinning ESPN/ABC 'a reasonably probable event' for late 2023
12/12/22 Morgan Stanley
Disney price target lowered to $115 from $125 at Morgan Stanley
AAPL Apple
$130.16 /

+0.59 (+0.46%)

01/10/23 BofA
Broadcom loss of Apple socket immaterial for 2-plus years, says BofA
01/09/23 Bernstein
Apple price target lowered to $125 from $170 at Bernstein
01/09/23 Wells Fargo
Qorvo price target raised to $90 from $80 at Wells Fargo
01/04/23 Tigress Financial
Apple production headwinds bring buying opportunity, says Tigress
AMYT Amryt Pharma
$14.51 /

+7.425 (+104.80%)

01/10/23 Maxim
Amryt Pharma downgraded to Hold from Buy at Maxim
01/10/23 Maxim
Amryt Pharma downgraded to Hold from Buy at Maxim
01/10/23 Canaccord
Amryt Pharma downgraded to Hold from Buy at Canaccord
01/10/23 Cantor Fitzgerald
Amryt Pharma downgraded to Neutral from Overweight at Cantor Fitzgerald
RVNC Revance
$30.41 /

+10.69 (+54.21%)

01/10/23 Needham
Revance price target raised to $38 from $35 at Needham
12/23/22 Needham
Cytokinetics added to 'Conviction List' and named '2023 Top Pick' at Needham
11/16/22 Barclays
Revance price target raised to $37 from $35 at Barclays
10/11/22 Morgan Stanley
Revance initiated with an Equal Weight at Morgan Stanley
CVAC CureVac
$10.34 /

+2.09 (+25.33%)

01/09/23 Jefferies
CureVac upgraded to Buy at Jefferies after mRNA platform validation
01/09/23 Jefferies
CureVac upgraded to Buy from Hold at Jefferies
01/08/23 BofA
CureVac 'likely too late for COVID upside,' says BofA
01/07/23 Jefferies
CureVac upgraded to Buy from Hold at Jefferies
CUTR Cutera
$30.99 /

-9.32 (-23.12%)

01/09/23 Piper Sandler
Cutera selloff on miss a buying opportunity, says Piper Sandler
12/28/22 Stephens
Cutera price target lowered to $68 from $78 at Stephens
12/08/22 Piper Sandler
Piper Sandler says buy Cutera shares on today's weakness
11/22/22 Piper Sandler
Piper would take advantage of any softness in Cutera after competitor approval
CERS Cerus
$2.72 /

-1.07 (-28.27%)

M Macy's
$20.44 /

-1.69 (-7.64%)

01/10/23 Deutsche Bank
Macy's price target lowered to $22 from $23 at Deutsche Bank
01/04/23 Deutsche Bank
Macy's price target lowered to $23 from $24 at Deutsche Bank
01/03/23 JPMorgan
Macy's price target lowered to $28 from $29 at JPMorgan
11/18/22 Deutsche Bank
Macy's price target lowered to $24 from $25 at Deutsche Bank
DXCM DexCom
$110.07 /

-5.77 (-4.98%)

01/09/23 Piper Sandler
Piper defending DexCom 'aggressively' after Q4 preannouncement
12/20/22 Stifel
DexCom price target raised to $130 from $120 at Stifel
12/12/22 Citi
DexCom price target raised to $146 from $117 at Citi
10/28/22 Cowen
DexCom price target raised to $114 from $85 at Cowen
ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

01/09/23 Piper Sandler
Piper Sandler reiterates Overweight on Alphatec after solid Q4 beat, 2023 guide
10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
PFE Pfizer
$48.38 /

-2.525 (-4.96%)

01/04/23 BofA
BioMarin price target raised to $200, added to 'US 1 List' at BofA
01/04/23 BofA
Pfizer downgraded to Neutral at BofA on COVID-19 uncertainty
01/04/23 BofA
Pfizer downgraded to Neutral from Buy at BofA
SRPT Sarepta
$117.73 /

-4.36 (-3.57%)

01/10/23 Needham
Sarepta price target raised to $160 from $158 at Needham
01/10/23 Credit Suisse
Sarepta price target raised to $114 from $101 at Credit Suisse
01/05/23 Jefferies
Nippon Shinyaku upgraded to Hold from Underperform at Jefferies
12/29/22 Cantor Fitzgerald
Sarepta has key catalysts in 2023, says Cantor Fitzgerald
Z Zillow
$38.74 /

+2.87 (+8.00%)

V Visa
$218.59 /

+0.77 (+0.35%)

UBER Uber
$27.40 /

+1.015 (+3.85%)

SRPT Sarepta
$117.73 /

-4.36 (-3.57%)

RVNC Revance
$30.41 /

+10.69 (+54.21%)

PFE Pfizer
$48.38 /

-2.525 (-4.96%)

PAYA Paya Holdings
$9.69 /

+1.895 (+24.33%)

NVEI Nuvei
$27.93 /

+0.93 (+3.44%)

MRNA Moderna
$183.90 /

+3.51 (+1.95%)

MA MasterCard
$371.05 /

+3.15 (+0.86%)

M Macy's
$20.44 /

-1.69 (-7.64%)

LULU Lululemon
$298.59 /

-30.89 (-9.38%)

GDDY GoDaddy
$74.32 /

-0.2 (-0.27%)

DXCM DexCom
$110.07 /

-5.77 (-4.98%)

DIS Disney
$94.78 /

+0.86 (+0.92%)

DCT Duck Creek Technologies
$19.04 /

+6.045 (+46.52%)

DASH DoorDash
$48.06 /

+0.045 (+0.09%)

CVAC CureVac
$10.34 /

+2.09 (+25.33%)

CUTR Cutera
$30.99 /

-9.32 (-23.12%)

CS Credit Suisse
$3.35 /

+0.075 (+2.29%)

CMCSA Comcast
$37.55 /

-0.31 (-0.82%)

CINC CinCor Pharma
$28.70 /

+16.885 (+142.91%)

CERS Cerus
$2.72 /

-1.07 (-28.27%)

AZN AstraZeneca
$70.89 /

+0.1 (+0.14%)

ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

AMYT Amryt Pharma
$14.51 /

+7.425 (+104.80%)

ALBO Albireo Pharma
$43.85 /

+21.05 (+92.32%)

AAPL Apple
$130.16 /

+0.59 (+0.46%)

  • 13
    Sep
  • 11
    Aug
Z Zillow
$38.74 /

+2.87 (+8.00%)

V Visa
$218.59 /

+0.77 (+0.35%)

UBER Uber
$27.40 /

+1.015 (+3.85%)

PFE Pfizer
$48.38 /

-2.525 (-4.96%)

MRNA Moderna
$183.90 /

+3.51 (+1.95%)

MA MasterCard
$371.05 /

+3.15 (+0.86%)

M Macy's
$20.44 /

-1.69 (-7.64%)

LULU Lululemon
$298.59 /

-30.89 (-9.38%)

GDDY GoDaddy
$74.32 /

-0.2 (-0.27%)

DIS Disney
$94.78 /

+0.86 (+0.92%)

DASH DoorDash
$48.06 /

+0.045 (+0.09%)

CS Credit Suisse
$3.35 /

+0.075 (+2.29%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$37.55 /

-0.31 (-0.82%)

AZN AstraZeneca
$70.89 /

+0.1 (+0.14%)

ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

AAPL Apple
$130.16 /

+0.59 (+0.46%)

Z Zillow
$38.74 /

+2.87 (+8.00%)

V Visa
$218.59 /

+0.77 (+0.35%)

SRPT Sarepta
$117.73 /

-4.36 (-3.57%)

RVNC Revance
$30.41 /

+10.69 (+54.21%)

PFE Pfizer
$48.38 /

-2.525 (-4.96%)

NVEI Nuvei
$27.93 /

+0.93 (+3.44%)

MRNA Moderna
$183.90 /

+3.51 (+1.95%)

MA MasterCard
$371.05 /

+3.15 (+0.86%)

M Macy's
$20.44 /

-1.69 (-7.64%)

LULU Lululemon
$298.59 /

-30.89 (-9.38%)

IPSEY Ipsen
$26.39 /

+ (+0.00%)

DXCM DexCom
$110.07 /

-5.77 (-4.98%)

DIS Disney
$94.78 /

+0.86 (+0.92%)

DCT Duck Creek Technologies
$19.04 /

+6.045 (+46.52%)

CUTR Cutera
$30.99 /

-9.32 (-23.12%)

CS Credit Suisse
$3.35 /

+0.075 (+2.29%)

CMCSA Comcast
$37.55 /

-0.31 (-0.82%)

CINC CinCor Pharma
$28.70 /

+16.885 (+142.91%)

AZN AstraZeneca
$70.89 /

+0.1 (+0.14%)

ATEC Alphatec
$11.95 /

-0.61 (-4.86%)

ALBO Albireo Pharma
$43.85 /

+21.05 (+92.32%)

AAPL Apple
$130.16 /

+0.59 (+0.46%)

Z Zillow
$38.74 /

+2.87 (+8.00%)

V Visa
$218.59 /

+0.77 (+0.35%)

UBER Uber
$27.40 /

+1.015 (+3.85%)

RVNC Revance
$30.41 /

+10.69 (+54.21%)

PFE Pfizer
$48.38 /

-2.525 (-4.96%)

MRNA Moderna
$183.90 /

+3.51 (+1.95%)

MA MasterCard
$371.05 /

+3.15 (+0.86%)

M Macy's
$20.44 /

-1.69 (-7.64%)

LULU Lululemon
$298.59 /

-30.89 (-9.38%)

DXCM DexCom
$110.07 /

-5.77 (-4.98%)

DIS Disney
$94.78 /

+0.86 (+0.92%)

DASH DoorDash
$48.06 /

+0.045 (+0.09%)

CS Credit Suisse
$3.35 /

+0.075 (+2.29%)

CMCSA Comcast
$37.55 /

-0.31 (-0.82%)

CINC CinCor Pharma
$28.70 /

+16.885 (+142.91%)

AZN AstraZeneca
$70.89 /

+0.1 (+0.14%)

AAPL Apple
$130.16 /

+0.59 (+0.46%)

On The Fly
What You Missed On Wall Street This Morning » 12:13
01/09/23
01/09
12:13
01/09/23
12:13
ZG

Zillow Group

$37.92 /

+2.95 (+8.44%)

, CMCSA

Comcast

$37.75 /

-0.11 (-0.29%)

, NVEI

Nuvei

$28.09 /

+1.09 (+4.04%)

, PAYA

Paya Holdings

$9.69 /

+1.895 (+24.33%)

, AZN

AstraZeneca

$71.22 /

+0.43 (+0.61%)

, CINC

CinCor Pharma

$28.42 /

+16.605 (+140.54%)

, ALBO

Albireo Pharma

$43.99 /

+21.19 (+92.94%)

, DCT

Duck Creek Technologies

$19.10 /

+6.105 (+46.98%)

, LULU

Lululemon

$303.42 /

-26.06 (-7.91%)

, Z

Zillow

$38.86 /

+2.99 (+8.34%)

, MA

MasterCard

$373.96 /

+6.06 (+1.65%)

, V

Visa

$221.40 /

+3.58 (+1.64%)

, UBER

Uber

$27.87 /

+1.49 (+5.65%)

, DASH

DoorDash

$49.22 /

+1.21 (+2.52%)

, GDDY

GoDaddy

$75.01 /

+0.49 (+0.66%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, LMT

Lockheed Martin

$464.21 /

-9.07 (-1.92%)

, RAD

Rite Aid

$3.65 /

+0.195 (+5.64%)

, CS

Credit Suisse

$3.40 /

+0.12 (+3.66%)

, CRM

Salesforce

$147.78 /

+7.295 (+5.19%)

, AMYT

Amryt Pharma

$14.60 /

+7.515 (+106.07%)

, RVNC

Revance

$28.33 /

+8.61 (+43.66%)

, CVAC

CureVac

$10.58 /

+2.33 (+28.24%)

, CUTR

Cutera

$32.12 /

-8.19 (-20.32%)

, CERS

Cerus

$2.93 /

-0.86 (-22.72%)

, M

Macy's

$20.53 /

-1.6 (-7.23%)

, DXCM

DexCom

$108.89 /

-6.95 (-6.00%)

, BRKR

Bruker

$64.80 /

-2.645 (-3.92%)

, MRNA

Moderna

$185.51 /

+5.12 (+2.84%)

, ATEC

Alphatec

$11.93 /

-0.63 (-5.02%)

, IPSEY

Ipsen

$26.39 /

+ (+0.00%)

Get caught up quickly on…

ShowHide Related Items >><<
ZG Zillow Group
$37.92 /

+2.95 (+8.44%)

Z Zillow
$38.86 /

+2.99 (+8.34%)

V Visa
$221.40 /

+3.58 (+1.64%)

UBER Uber
$27.87 /

+1.49 (+5.65%)

RVNC Revance
$28.33 /

+8.61 (+43.66%)

RAD Rite Aid
$3.65 /

+0.195 (+5.64%)

NVEI Nuvei
$28.09 /

+1.09 (+4.04%)

MRNA Moderna
$185.51 /

+5.12 (+2.84%)

MA MasterCard
$373.96 /

+6.06 (+1.65%)

M Macy's
$20.53 /

-1.6 (-7.23%)

LULU Lululemon
$303.42 /

-26.06 (-7.91%)

LMT Lockheed Martin
$464.21 /

-9.07 (-1.92%)

IPSEY Ipsen
$26.39 /

+ (+0.00%)

GDDY GoDaddy
$75.01 /

+0.49 (+0.66%)

DXCM DexCom
$108.89 /

-6.95 (-6.00%)

DCT Duck Creek Technologies
$19.10 /

+6.105 (+46.98%)

DASH DoorDash
$49.22 /

+1.21 (+2.52%)

CVAC CureVac
$10.58 /

+2.33 (+28.24%)

CUTR Cutera
$32.12 /

-8.19 (-20.32%)

CS Credit Suisse
$3.40 /

+0.12 (+3.66%)

CRM Salesforce
$147.78 /

+7.295 (+5.19%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$37.75 /

-0.11 (-0.29%)

CINC CinCor Pharma
$28.42 /

+16.605 (+140.54%)

CERS Cerus
$2.93 /

-0.86 (-22.72%)

BRKR Bruker
$64.80 /

-2.645 (-3.92%)

AZN AstraZeneca
$71.22 /

+0.43 (+0.61%)

ATEC Alphatec
$11.93 /

-0.63 (-5.02%)

AMYT Amryt Pharma
$14.60 /

+7.515 (+106.07%)

ALBO Albireo Pharma
$43.99 /

+21.19 (+92.94%)

ZG Zillow Group
$37.92 /

+2.95 (+8.44%)

01/09/23 BofA
Zillow Group upgraded to Buy from Underperform at BofA
12/21/22 Piper Sandler
Piper says slowing housing market still a 'headwind' for Redfin, Zillow
12/13/22 Citi
Zillow Group initiated with a Buy at Citi
12/02/22 UBS
Zillow Group initiated with a Buy at UBS
CMCSA Comcast
$37.75 /

-0.11 (-0.29%)

01/06/23 MKM Partners
MKM Partners sees WWE as 'very attractive asset' if it goes for sale
01/05/23 Truist
Truist upgrades Comcast, Charter to Buy with risks 'well understood'
01/05/23 Truist
Comcast upgraded to Buy from Hold at Truist
12/12/22 Morgan Stanley
Comcast has catalysts for re-rating, says Morgan Stanley
NVEI Nuvei
$28.09 /

+1.09 (+4.04%)

01/09/23 Goldman Sachs
Nuvei upgraded to Buy from Neutral at Goldman Sachs
01/05/23 Wolfe Research
Nuvei price target lowered to $35 from $42 at Wolfe Research
10/10/22 Keefe Bruyette
Nuvei price target lowered to $48 from $52 at Keefe Bruyette
10/07/22 Wolfe Research
Nuvei initiated with an Outperform at Wolfe Research
PAYA Paya Holdings
$9.69 /

+1.895 (+24.33%)

01/09/23 William Blair
Paya Holdings downgraded to Market Perform from Outperform at William Blair
11/07/22 Northland
Paya Holdings price target raised to $10 from $9 at Northland
06/21/22 Raymond James
Global Payments the 'most likely' acquirer of Paya Holdings, says Raymond James
03/02/22 Canaccord
Paya Holdings price target lowered to $10 from $15 at Canaccord
AZN AstraZeneca
$71.22 /

+0.43 (+0.61%)

01/05/23 BMO Capital
AstraZeneca initiated with an Outperform at BMO Capital
01/03/23 JPMorgan
AstraZeneca price target raised to 13,500 GBp from 12,500 GBp at JPMorgan
12/15/22 Deutsche Bank
AstraZeneca price target raised to 13,000 GBp from 12,000 GBp at Deutsche Bank
11/04/22 Citi
Citi opens 'positive catalyst watch' AstraZeneca on NJ litigation outcomes
CINC CinCor Pharma
$28.42 /

+16.605 (+140.54%)

12/07/22 Barclays
CinCor Pharma initiated with an Overweight at Barclays
11/30/22 Jefferies
Jefferies defending CinCor Pharma 'at zero EV'
11/29/22 Morgan Stanley
CinCor Pharma downgraded on limited catalysts at Morgan Stanley
11/29/22 Morgan Stanley
CinCor Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
ALBO Albireo Pharma
$43.99 /

+21.19 (+92.94%)

01/09/23 Piper Sandler
Albireo acquisition 'good news' for Mirum Pharmaceuticals, says Piper Sandler
01/09/23 Wedbush
Albireo Pharma downgraded to Neutral from Outperform at Wedbush
10/24/22 Piper Sandler
Mirum's LIVMARLI PFIC data shows superiority to Albireo's Bylvay, says Piper
10/12/22 H.C. Wainwright
Albireo Pharma price target raised to $68 from $54 at H.C. Wainwright
DCT Duck Creek Technologies
$19.10 /

+6.105 (+46.98%)

01/04/23 BofA
Duck Creek Technologies downgraded to Underperform from Neutral at BofA
12/29/22 Raymond James
Duck Creek 2023 outlook 'much improved' on relative basis, says Raymond James
12/12/22 RBC Capital
Coupa Software upgraded to Sector Perform from Underperform at RBC Capital
12/01/22 JPMorgan
Duck Creek Technologies initiated with a Neutral at JPMorgan
LULU Lululemon
$303.42 /

-26.06 (-7.91%)

01/06/23 Wells Fargo
Lululemon upgraded to Overweight from Equal Weight at Wells Fargo
01/06/23 Wells Fargo
Lululemon upgraded to Overweight from Equal Weight at Wells Fargo
01/05/23 Piper Sandler
Lululemon price target lowered to $385 from $390 at Piper Sandler
12/12/22 Argus
Lululemon selloff presents buying opportunity, says Argus
Z Zillow
$38.86 /

+2.99 (+8.34%)

11/04/22 Evercore ISI
Zillow Group removed from 'Tactical Underperform' list at Evercore ISI
MA MasterCard
$373.96 /

+6.06 (+1.65%)

01/09/23 KeyBanc
MasterCard upgraded to Overweight from Sector Weight at KeyBanc
01/05/23 Wolfe Research
MasterCard price target raised to $415 from $395 at Wolfe Research
12/27/22 Wedbush
Wedbush says SpendingPulse data bodes well for Visa, MasterCard, and PayPal
12/27/22 Baird
Baird doubts FTC order will have 'material impact' on MasterCard
V Visa
$221.40 /

+3.58 (+1.64%)

01/09/23 KeyBanc
Visa upgraded to Overweight from Sector Weight at KeyBanc
01/05/23 Wolfe Research
Visa price target raised to $255 from $240 at Wolfe Research
12/02/22 Wells Fargo
Visa price target raised to $250 from $225 at Wells Fargo
UBER Uber
$27.87 /

+1.49 (+5.65%)

01/09/23 Jefferies
Uber assumed with a Buy at Jefferies
01/09/23 Piper Sandler
Uber upgraded to Overweight from Neutral at Piper Sandler
01/06/23 Needham
Genius Sports named 2023 Top Pick, added to Conviction List at Needham
01/03/23 BTIG
Expedia named Top Pick for first half of 2023 at BTIG
DASH DoorDash
$49.22 /

+1.21 (+2.52%)

01/09/23 Jefferies
DoorDash initiated with an Underperform at Jefferies
01/09/23 Piper Sandler
DoorDash downgraded to Underweight from Neutral at Piper Sandler
01/05/23 Mizuho
DoorDash price target lowered to $65 from $70 at Mizuho
GDDY GoDaddy
$75.01 /

+0.49 (+0.66%)

01/09/23 Jefferies
GoDaddy downgraded to Hold from Buy at Jefferies
12/13/22 Citi
GoDaddy initiated with a Buy at Citi
11/11/22 JPMorgan
GoDaddy initiated with an Overweight at JPMorgan
11/04/22 Raymond James
GoDaddy price target lowered to $88 from $100 at Raymond James
CMCSK Comcast
$58.00 /

+ (+0.00%)

09/27/22 Credit Suisse
Charter price target lowered to $551 from $676 at Credit Suisse
09/27/22 Credit Suisse
Comcast price target lowered to $51 from $57 at Credit Suisse
07/20/22 KeyBanc
Disney price target lowered to $131 from $151 at KeyBanc
05/23/22 Raymond James
Electronic Arts moves 'somewhat unexpected,' says Raymond James
LMT Lockheed Martin
$464.21 /

-9.07 (-1.92%)

12/15/22 Morgan Stanley
Lockheed Martin downgraded to Equal Weight from Overweight at Morgan Stanley
12/08/22 Citi
Lockheed Martin initiated with a Buy at Citi
12/06/22 Morgan Stanley
Textron's FLRAA win should be 'positively received,' says Morgan Stanley
12/05/22 Jefferies
Textron award estimated at $11 per share net present value, says Jefferies
RAD Rite Aid
$3.65 /

+0.195 (+5.64%)

10/03/22 Evercore ISI
Walgreens Boots Alliance price target lowered to $32 from $41 at Evercore ISI
10/03/22 Deutsche Bank
Rite Aid price target lowered to $3 from $4 at Deutsche Bank
09/30/22 Evercore ISI
Rite Aid removed from 'TAP Outperform' list at Evercore ISI, target cut to $4.50
06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
CS Credit Suisse
$3.40 /

+0.12 (+3.66%)

12/20/22 Exane BNP Paribas
Credit Suisse resumed with an Underperform at Exane BNP Paribas
12/20/22 Citi
Credit Suisse resumed with a Buy at Citi
12/19/22 RBC Capital
Credit Suisse reinstated with a Sector Perform at RBC Capital
12/09/22 BofA
BofA upgrades Credit Suisse to Buy, sees more than 20% upside potential
CRM Salesforce
$147.78 /

+7.295 (+5.19%)

01/09/23 Piper Sandler
Salesforce price target lowered to $171 from $175 at Piper Sandler
01/05/23 Loop Capital
Salesforce price target lowered to $140 from $150 at Loop Capital
01/05/23 Cowen
Salesforce price target lowered to $175 from $195 at Cowen
01/04/23 Jefferies
Salesforce restructuring plan 'a step in the right direction,' says Jefferies
AMYT Amryt Pharma
$14.60 /

+7.515 (+106.07%)

09/06/22 Canaccord
Amryt Pharma assumed with a Buy at Canaccord
03/10/22 H.C. Wainwright
Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright
03/01/22 Maxim
Amryt Pharma price target lowered to $18 from $27 at Maxim
03/01/22 Canaccord
Amryt Pharma price target lowered to $19 from $40 at Canaccord
RVNC Revance
$28.33 /

+8.61 (+43.66%)

12/23/22 Needham
Cytokinetics added to 'Conviction List' and named '2023 Top Pick' at Needham
11/16/22 Barclays
Revance price target raised to $37 from $35 at Barclays
10/11/22 Morgan Stanley
Revance initiated with an Equal Weight at Morgan Stanley
09/22/22 Goldman Sachs
Revance initiated with a Buy at Goldman Sachs
CVAC CureVac
$10.58 /

+2.33 (+28.24%)

01/09/23 Jefferies
CureVac upgraded to Buy at Jefferies after mRNA platform validation
01/09/23 Jefferies
CureVac upgraded to Buy from Hold at Jefferies
01/08/23 BofA
CureVac 'likely too late for COVID upside,' says BofA
01/07/23 Jefferies
CureVac upgraded to Buy from Hold at Jefferies
CUTR Cutera
$32.12 /

-8.19 (-20.32%)

01/09/23 Piper Sandler
Cutera selloff on miss a buying opportunity, says Piper Sandler
12/28/22 Stephens
Cutera price target lowered to $68 from $78 at Stephens
12/08/22 Piper Sandler
Piper Sandler says buy Cutera shares on today's weakness
11/22/22 Piper Sandler
Piper would take advantage of any softness in Cutera after competitor approval
CERS Cerus
$2.93 /

-0.86 (-22.72%)

M Macy's
$20.53 /

-1.6 (-7.23%)

01/04/23 Deutsche Bank
Macy's price target lowered to $23 from $24 at Deutsche Bank
01/03/23 JPMorgan
Macy's price target lowered to $28 from $29 at JPMorgan
11/18/22 Deutsche Bank
Macy's price target lowered to $24 from $25 at Deutsche Bank
11/18/22 Citi
Macy's price target raised to $25 from $21 at Citi
DXCM DexCom
$108.89 /

-6.95 (-6.00%)

01/09/23 Piper Sandler
Piper defending DexCom 'aggressively' after Q4 preannouncement
12/20/22 Stifel
DexCom price target raised to $130 from $120 at Stifel
12/12/22 Citi
DexCom price target raised to $146 from $117 at Citi
10/28/22 Cowen
DexCom price target raised to $114 from $85 at Cowen
BRKR Bruker
$64.80 /

-2.645 (-3.92%)

10/21/22 UBS
Bruker initiated with a Buy at UBS
08/22/22 Citi
Bruker upgraded to Buy from Neutral at Citi
MRNA Moderna
$185.51 /

+5.12 (+2.84%)

01/05/23 Morgan Stanley
Morgan Stanley sees Moderna's phase 3 RSV vaccine data as catalyst-driven idea
12/20/22 Piper Sandler
Moderna price target raised to $217 from $214 at Piper Sandler
12/19/22 Jefferies
Moderna upgraded to Buy from Hold at Jefferies
12/16/22 Morgan Stanley
Moderna price target raised to $209 from $170 at Morgan Stanley
ATEC Alphatec
$11.93 /

-0.63 (-5.02%)

01/09/23 Piper Sandler
Piper Sandler reiterates Overweight on Alphatec after solid Q4 beat, 2023 guide
10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
IPSEY Ipsen
$26.39 /

+ (+0.00%)

12/09/22 Oddo BHF
Ipsen downgraded to Neutral from Outperform at Oddo BHF
12/06/22 Barclays
Ipsen reinstated with an Equal Weight at Barclays
ZG Zillow Group
$37.92 /

+2.95 (+8.44%)

V Visa
$221.40 /

+3.58 (+1.64%)

UBER Uber
$27.87 /

+1.49 (+5.65%)

RVNC Revance
$28.33 /

+8.61 (+43.66%)

RAD Rite Aid
$3.65 /

+0.195 (+5.64%)

PAYA Paya Holdings
$9.69 /

+1.895 (+24.33%)

NVEI Nuvei
$28.09 /

+1.09 (+4.04%)

MRNA Moderna
$185.51 /

+5.12 (+2.84%)

MA MasterCard
$373.96 /

+6.06 (+1.65%)

M Macy's
$20.53 /

-1.6 (-7.23%)

LULU Lululemon
$303.42 /

-26.06 (-7.91%)

LMT Lockheed Martin
$464.21 /

-9.07 (-1.92%)

GDDY GoDaddy
$75.01 /

+0.49 (+0.66%)

DXCM DexCom
$108.89 /

-6.95 (-6.00%)

DCT Duck Creek Technologies
$19.10 /

+6.105 (+46.98%)

DASH DoorDash
$49.22 /

+1.21 (+2.52%)

CVAC CureVac
$10.58 /

+2.33 (+28.24%)

CUTR Cutera
$32.12 /

-8.19 (-20.32%)

CS Credit Suisse
$3.40 /

+0.12 (+3.66%)

CRM Salesforce
$147.78 /

+7.295 (+5.19%)

CMCSA Comcast
$37.75 /

-0.11 (-0.29%)

CINC CinCor Pharma
$28.42 /

+16.605 (+140.54%)

CERS Cerus
$2.93 /

-0.86 (-22.72%)

BRKR Bruker
$64.80 /

-2.645 (-3.92%)

AZN AstraZeneca
$71.22 /

+0.43 (+0.61%)

ATEC Alphatec
$11.93 /

-0.63 (-5.02%)

AMYT Amryt Pharma
$14.60 /

+7.515 (+106.07%)

ALBO Albireo Pharma
$43.99 /

+21.19 (+92.94%)

  • 13
    Sep
  • 11
    Aug
ZG Zillow Group
$37.92 /

+2.95 (+8.44%)

V Visa
$221.40 /

+3.58 (+1.64%)

UBER Uber
$27.87 /

+1.49 (+5.65%)

RAD Rite Aid
$3.65 /

+0.195 (+5.64%)

MRNA Moderna
$185.51 /

+5.12 (+2.84%)

MA MasterCard
$373.96 /

+6.06 (+1.65%)

M Macy's
$20.53 /

-1.6 (-7.23%)

LULU Lululemon
$303.42 /

-26.06 (-7.91%)

LMT Lockheed Martin
$464.21 /

-9.07 (-1.92%)

GDDY GoDaddy
$75.01 /

+0.49 (+0.66%)

DASH DoorDash
$49.22 /

+1.21 (+2.52%)

CS Credit Suisse
$3.40 /

+0.12 (+3.66%)

CRM Salesforce
$147.78 /

+7.295 (+5.19%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$37.75 /

-0.11 (-0.29%)

AZN AstraZeneca
$71.22 /

+0.43 (+0.61%)

ATEC Alphatec
$11.93 /

-0.63 (-5.02%)

ZG Zillow Group
$37.92 /

+2.95 (+8.44%)

V Visa
$221.40 /

+3.58 (+1.64%)

UBER Uber
$27.87 /

+1.49 (+5.65%)

RVNC Revance
$28.33 /

+8.61 (+43.66%)

RAD Rite Aid
$3.65 /

+0.195 (+5.64%)

MRNA Moderna
$185.51 /

+5.12 (+2.84%)

MA MasterCard
$373.96 /

+6.06 (+1.65%)

M Macy's
$20.53 /

-1.6 (-7.23%)

LULU Lululemon
$303.42 /

-26.06 (-7.91%)

LMT Lockheed Martin
$464.21 /

-9.07 (-1.92%)

IPSEY Ipsen
$26.39 /

+ (+0.00%)

DXCM DexCom
$108.89 /

-6.95 (-6.00%)

DCT Duck Creek Technologies
$19.10 /

+6.105 (+46.98%)

DASH DoorDash
$49.22 /

+1.21 (+2.52%)

CUTR Cutera
$32.12 /

-8.19 (-20.32%)

CS Credit Suisse
$3.40 /

+0.12 (+3.66%)

CRM Salesforce
$147.78 /

+7.295 (+5.19%)

CMCSA Comcast
$37.75 /

-0.11 (-0.29%)

CINC CinCor Pharma
$28.42 /

+16.605 (+140.54%)

AZN AstraZeneca
$71.22 /

+0.43 (+0.61%)

ATEC Alphatec
$11.93 /

-0.63 (-5.02%)

ALBO Albireo Pharma
$43.99 /

+21.19 (+92.94%)

Z Zillow
$38.86 /

+2.99 (+8.34%)

V Visa
$221.40 /

+3.58 (+1.64%)

UBER Uber
$27.87 /

+1.49 (+5.65%)

RVNC Revance
$28.33 /

+8.61 (+43.66%)

RAD Rite Aid
$3.65 /

+0.195 (+5.64%)

MRNA Moderna
$185.51 /

+5.12 (+2.84%)

MA MasterCard
$373.96 /

+6.06 (+1.65%)

M Macy's
$20.53 /

-1.6 (-7.23%)

LULU Lululemon
$303.42 /

-26.06 (-7.91%)

LMT Lockheed Martin
$464.21 /

-9.07 (-1.92%)

DXCM DexCom
$108.89 /

-6.95 (-6.00%)

DASH DoorDash
$49.22 /

+1.21 (+2.52%)

CS Credit Suisse
$3.40 /

+0.12 (+3.66%)

CRM Salesforce
$147.78 /

+7.295 (+5.19%)

CMCSA Comcast
$37.75 /

-0.11 (-0.29%)

CINC CinCor Pharma
$28.42 /

+16.605 (+140.54%)

AZN AstraZeneca
$71.22 /

+0.43 (+0.61%)

Recommendations
Piper Sandler reiterates Overweight on Alphatec after solid Q4 beat, 2023 guide » 10:42
01/09/23
01/09
10:42
01/09/23
10:42
ATEC

Alphatec

$12.00 /

-0.555 (-4.42%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien notes that Alphatec preannounced preliminary Q4 results, which easily exceeded the Street on the top-line, and provided its initial 2023 outlook, which calls for total sales of $438M. The company continues to see strong adoption of PTP, which fueled Surgical Revenue growth of 48%-50%. When comparing the performance with other pure-play spine names, it is clear to O'Brien that Alphatec is gaining broad-based market share, and he is "encouraged" to see the strong momentum continuing into 2023. The company also announced the closing of a five-year, $150M non-dilutive term loan which will strengthen the balance sheet. All in, the analyst thinks Alphatec can deliver some of the best growth in all of spine for years to come, and reiterates an Overweight rating on the shares with a price target of $17.

ShowHide Related Items >><<
ATEC Alphatec
$12.00 /

-0.555 (-4.42%)

ATEC Alphatec
$12.00 /

-0.555 (-4.42%)

10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
10/10/22 Piper Sandler
Piper Sandler bullish on Alphatec following Q3 preliminary results
ATEC Alphatec
$12.00 /

-0.555 (-4.42%)

ATEC Alphatec
$12.00 /

-0.555 (-4.42%)

ATEC Alphatec
$12.00 /

-0.555 (-4.42%)

Earnings
Alphatec sees FY23 revenue $438M, consensus $412.41M » 09:28
01/09/23
01/09
09:28
01/09/23
09:28
ATEC

Alphatec

$12.59 /

+0.535 (+4.44%)

The company said,…

The company said, "The Company anticipates full-year 2023 total revenue of $438 million, reflecting growth of approximately 25% compared to the full-year 2022. This includes surgical revenue of $383 million and approximately $55 million of EOS revenue. The Company expects to achieve non-GAAP adjusted EBITDA break-even for the full-year 2023."

ShowHide Related Items >><<
ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
10/10/22 Piper Sandler
Piper Sandler bullish on Alphatec following Q3 preliminary results
ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

Earnings
Alphatec sees FY22 revenue $350.1M-$351.1M, consensus $340.28M  09:27
01/09/23
01/09
09:27
01/09/23
09:27
ATEC

Alphatec

$12.59 /

+0.535 (+4.44%)

 
ShowHide Related Items >><<
ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
10/10/22 Piper Sandler
Piper Sandler bullish on Alphatec following Q3 preliminary results
ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

Earnings
Alphatec reports preliminary Q4 revenue $105.2M-$106.2M, consensus $95.3M » 09:24
01/09/23
01/09
09:24
01/09/23
09:24
ATEC

Alphatec

$12.59 /

+0.535 (+4.44%)

"Our commitment to…

"Our commitment to delivering unmatched procedural sophistication drove sector-leading growth once again in 2022," said Pat Miles, chairman and CEO. "As we look to the year ahead, we are as bullish as ever! We intend to continue to not just penetrate, but expand the market for lateral spine surgery and advance the influence of EOS. Our strategy to earn surgeon confidence through clinical distinction has and will continue to set ATEC apart, enabling us to successfully execute our strategic and financial commitments."

ShowHide Related Items >><<
ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
10/10/22 Piper Sandler
Piper Sandler bullish on Alphatec following Q3 preliminary results
ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

ATEC Alphatec
$12.59 /

+0.535 (+4.44%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.